case_images: PMC10666624_01
case_images: PMC10666624_02
case_images: PMC10666624_03
case_images: CRP values at the beginning of therapy with MMF and in the course of therapy.
case_images: fmed-10-1254747-g001.jpg
case_images: PMC10666624_03_fmed-10-1254747-g001.jpg
case_images: fig1
case_images: CRP levels dropped from 28.1 mg/L at diagnosis to 0.5 mg/L after 3 months of MMF treatment (see Figure 1). 18F-FDG PET 1 year later, after discontinuing MMF, showed a marked signal (see Figure 2).
case_images: (A) 08/17 Maximum-intensity projection (MIP) 18F-FDG PET image showing active large vessel vasculitis in a 3-year-old male patient. (B-G) Transversal fused PET/CT and PET images showing high inflammatory arterial wall signal in the aortic arch (B,C) and the thoracic (D,E) and abdominal aorta (F,G). (H-N) 12/2017 Corresponding PET images after treatment showing markedly reduced signal within arterial walls.
case_images: fmed-10-1254747-g002.jpg
case_images: PMC10666624_03_fmed-10-1254747-g002.jpg
case_images: fig2
case_images: CRP levels dropped from 28.1 mg/L at diagnosis to 0.5 mg/L after 3 months of MMF treatment (see Figure 1). 18F-FDG PET 1 year later, after discontinuing MMF, showed a marked signal (see Figure 2).
case_images: PMC10666624_04
case_images: PMC10666624_05
case_images: PMC10666624_06
case_images: PMC10666624_07